- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02208141
Leipzig Adipose Tissue Childhood Cohort
November 3, 2023 updated by: Antje Koerner, Prof. Dr. med., University of Leipzig
Determinants of Adipose Tissue Development and Obesity in Children and Adolescents
In this study the investigators hypothesize that pathological alterations in adipose tissue biology already occur during the development and progression of obesity in children and adolescents.
The investigators aim to identify and characterize mechanisms and molecular targets that affect the development of adipose tissue and ensuing obesity in childhood and adolescence.
Study Overview
Status
Recruiting
Conditions
Detailed Description
The investigators aim to identify how adipose tissue dysfunction in childhood contributes to the development of obesity and related comorbidities and to characterize factors that play a role in the development of adipose dysfunction in children.
The investigators will employ a translational approach which is based on the characterization of adipose tissue biology in samples of children to determine alterations leading to adipose tissue dysfunction.
These include assessment of the composition (including BAT), remodeling, function, metabolism and inflammation of adipose tissue as well as the adipokine profile.
For the assessment of clinical relevance, these experimental data will then be correlated with the clinical phenotype.
Finally, we aim to identify factors responsible for early adipose tissue dysfunction and characterize them for their clinical and functional relevance.
Study Type
Observational
Enrollment (Estimated)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Antje Körner, Prof. Dr.
- Phone Number: 0049/(0)341-9726854
- Email: Antje.Koerner@medizin.uni-leipzig.de
Study Contact Backup
- Name: Robert Stein, MD
- Phone Number: 0049/(0)341-9726537
- Email: Robert.stein@medizin.uni-leipzig.de
Study Locations
-
-
Sachsen
-
Leipzig, Sachsen, Germany, 04103
- Recruiting
- Center for Pediatric Research Leipzig (CPL)
-
Contact:
- Antje Körner, Prof. Dr.
- Phone Number: 0049/(0)341-9726854
- Email: Antje.Koerner@medizin.uni-leipzig.de
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
children and adolescents undergoing surgery at the University Hospital Leipzig
Description
Inclusion Criteria:
- body weight: 3000 g - 180 kg
- suitable surgical procedure
- signed informed consent by the guardians and the study participant, if older 12 years
Exclusion Criteria:
- severe chronic and inflammatory diseases
- acute or chronic infections
- oncological diseases
- clotting disorders
- complications during surgical procedure
- drug treatment
- nil by mouth
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
lean and obese children and adolescents
study cohort may be stratified for lean (definded as BMI <1.28 SDS) and overweight/obese (definded as BMI>= 1.28 SDS) children for posthoc analyses no intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adipose tissue dysfunction
Time Frame: 10 years
|
Adipose tissue dysfunction is assessed by evaluation of adipocyte size and number (hypertrophy vs. hyperplasia), adipocyte proliferation and differentiation, (lipid) cellular metabolism, inflammation, gene expression, fibrosis, and others; the association of AT dysfunction with clincial phenotype will be assessed
|
10 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Presence of brown adipose tissue (BAT)
Time Frame: 10 years
|
Adipose tissue samples will be evaluated for the presence of BAT on histological and molecular level and association with clinical phenotype will be investigated
|
10 years
|
|
Inflammation of adipose tissue
Time Frame: 10 years
|
Inflammation will be assessed by evaluating macrophage infiltration on histological and molecular expression level.
Also, association with clinical phenotype will be assessed.
|
10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Antje Körner, Prof. Dr., University of Leipzig
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Primary Completion (Estimated)
December 1, 2030
Study Completion (Estimated)
December 1, 2030
Study Registration Dates
First Submitted
June 12, 2014
First Submitted That Met QC Criteria
August 1, 2014
First Posted (Estimated)
August 4, 2014
Study Record Updates
Last Update Posted (Actual)
November 7, 2023
Last Update Submitted That Met QC Criteria
November 3, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IFB ADI K7-10
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insulin Resistance
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedEndoplasmic Reticulum Stress | HIV Related Insulin Resistance | Protease Inhibitor Related Insulin ResistanceUnited States
-
German Diabetes CenterYale UniversityRecruiting
-
George Washington UniversityCompletedInsulin Sensitivity/ResistanceUnited States
-
Paloma Almeda-ValdésCompleted
-
National Institute of Diabetes and Digestive and...Active, not recruitingSevere Insulin ResistanceUnited States
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
National Taiwan UniversityNational Cheng-Kung University HospitalCompletedExercise, Insulin Resistance, Visceral Adipose TissueTaiwan
-
Société des Produits Nestlé (SPN)CompletedInsulin Sensitivity/ResistanceSwitzerland
-
University of CopenhagenNovo Nordisk A/S; Queen Mary University of London; University of SydneyNot yet recruitingInsulin Sensitivity/Resistance | Metabolic HealthDenmark
-
Assiut UniversityCompleted